Last reviewed · How we verify

NCT02875808

Cerebrospinal Fluid IL-6, IL-8 and PCT as Early Marker of an Intrathecal Infection in Neurosurgical Patients

Completed Last updated 6 November 2018
What this trial tests

trial in Intrathecal Infection in 50 participants. Completed in 12 December 2017.

Timeline
1 August 2014
Primary endpoint
1 September 2016
12 December 2017

Quick facts

Lead sponsorUniversity Medicine Greifswald
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 August 2014
Primary completion1 September 2016
Estimated completion12 December 2017
Sites1 location across Germany

Conditions studied

Sponsor

University Medicine Greifswald

Who can join

Eligibility, any sex, with Intrathecal Infection or External Ventricular Drainage Associated Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The value of CSF IL-6, IL-8 and Procalcitonin in detecting an early diagnosis of intrathecal infection in neurosurgical patients with an external ventricular drainage is evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Medicine Greifswald trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02875808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing